Skip to main content

What Angelina Jolie forgot to mention

By H. Gilbert Welch, Special to CNN
May 18, 2013 -- Updated 1425 GMT (2225 HKT)
Known for her humanitarian works and action movies, Angelina Jolie is an actress who has been in the spotlight since she was a child. Here's a look at her life. Known for her humanitarian works and action movies, Angelina Jolie is an actress who has been in the spotlight since she was a child. Here's a look at her life.
HIDE CAPTION
Life of Angelina Jolie
Life of Angelina Jolie
Life of Angelina Jolie
Life of Angelina Jolie
Life of Angelina Jolie
Life of Angelina Jolie
Life of Angelina Jolie
Life of Angelina Jolie
Life of Angelina Jolie
Life of Angelina Jolie
Life of Angelina Jolie
Life of Angelina Jolie
Life of Angelina Jolie
Life of Angelina Jolie
Life of Angelina Jolie
Life of Angelina Jolie
Life of Angelina Jolie
Life of Angelina Jolie
Life of Angelina Jolie
Life of Angelina Jolie
Photos: Life of Angelina Jolie
<<
<
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
>
>>
STORY HIGHLIGHTS
  • Professor of medicine Gil Welch surprised by huge reaction to Angelina Jolie's op-ed
  • Welch fears women might wonder if they, too, should have preventive mastectomies
  • Welch: But 99% of women do not carry the BRCA1 mutation that raises the risk of breast cancer
  • He says women should look at family history before getting tested for the mutation

Editor's note: H. Gilbert Welch is a professor of medicine at the Dartmouth Institute for Health Policy and Clinical Practice and a co-author of "Overdiagnosed: Making People Sick in the Pursuit of Health."

(CNN) -- I first saw the headline early Tuesday on Real Clear Politics, a political news site where I generally start my morning. It's not where I expect to see a story on breast cancer.

Then I checked my e-mail messages -- they all seemed to be about Angelina Jolie's op-ed. Students in my undergraduate class wanted to discuss it in our next session. Colleagues expressed concern and wondered what the right response was. People I don't even know sent e-mails.

One, from a research fellow at the International Agency for Research on Cancer, nicely summed up the general concern: "I fear that this disclosure will motivate other women to undergo preventive mastectomy, even though they do not need it."

Wow. Maybe I should read it.

H. Gilbert Welch
H. Gilbert Welch

I did. I found it to be a moving story and understood her choice. What I couldn't understand initially was the concern expressed by others.

As the day wore on, the story dominated the news. I didn't fully appreciate how much Ms. Jolie is admired and respected and had neglected to consider just how powerful a celebrity personal anecdote could be.

If American women saw themselves in Angelina Jolie -- then that would be a problem. Because the logical next question is: Should I get a preventive mastectomy?

Then I realized something was missing in her piece; something that should have been printed in big black letters:

NOTE: This story is not relevant to more than 99% of American women.

Angelina Jolie reveals double mastectomy
CNN anchor: I have breast cancer
Support pours in for Angelina Jolie

Why? Because more than 99% of women do not have the BRCA1 mutation -- or the BRCA2 mutation, for that matter.

Let's be clear, the BRCA1 mutation is a bad thing. Although I might quibble with the exact numbers in the piece, the big picture is this: the mutation increases the risk of developing breast cancer about five fold and increases the risk of ovarian cancer more than 10 fold.

It is a powerful risk factor for these cancers -- almost as powerful as cigarette smoking is for lung cancer.

When people are at very high risk for something bad to happen, preventive interventions are more likely to be a good deal; that is, the benefits are likely to exceed the harms. I'm not saying that prophylactic mastectomy is the right choice for a woman with BRCA1, simply that it is a reasonable one.

When people are at average risk, the deal changes. The opportunity for benefit is less, simply because the bad event is less likely to happen. But the harms of preventive intervention remain roughly the same.

It is a fundamental precept of medicine -- one I hammer home with undergraduates (future patients) and medical students (future doctors): Patients with severe abnormalities stand to gain more from intervention than patients with mild ones. Patients with mild abnormalities are more likely to experience net harm from intervention, simply because they have less opportunity to benefit.

The vast majority of women don't have the BRCA1 mutation. They are at average risk for breast cancer. They are not Angelina Jolie. They should not have a preventive mastectomy.

A few weeks ago, in a New York Times Magazine piece, Peggy Orenstein related her first instinct when facing breast cancer recurrence: take the other breast too. Her oncologist responded with a simple question: "Would an average woman cut off her breasts?"

I hope not.

But there is a second question for women raised by Ms. Jolie's piece: Should I be tested for BRCA1?

She seems to believe the answer is yes, pointing to the half-million women who die from breast cancer worldwide each year. But she neglects to point out that 90% of these deaths have nothing to do with the BRCA1 mutation. That's because most women don't have the mutation and because most breast cancer is sporadic.

Opinion: Jolie's choice: Risks and benefits

The few women who are likely to have the mutation are also likely to know they may have it based on the oldest genetic test of all: a strong family history of cancer.

Population-wide screening raises complex issues. We would want to know more about how often the test is wrong, particularly how often the test is falsely positive. That's important because women falsely diagnosed as a mutation carrier might undergo prophylactic mastectomy unnecessarily. Then there are the psychological effects, not only for the patient but also for her siblings and offspring.

We'd also need to know more about what a BRCA1 mutation means in the absence of family history. Ms. Jolie's mother died of ovarian cancer at age 56. I'm no geneticist, but I can guess that puts her at higher risk -- both for having the mutation and for developing a bad cancer.

And we'd certainly want an answer to the question: Must the test cost so much?

There's no one right choice for a woman in Angelina Jolie's position, but she may well have made the right choice for her. Luckily it is a choice most women don't have to face.

Follow us on Twitter @CNNOpinion.

Join us on Facebook/CNNOpinion.

The opinions expressed in this commentary are solely those of H. Gilbert Welch.

ADVERTISEMENT
Part of complete coverage on
April 22, 2014 -- Updated 2247 GMT (0647 HKT)
Q & A with artist Rachel Sussman on her new book of photographs, "The Oldest Living Things in the World."
April 22, 2014 -- Updated 1958 GMT (0358 HKT)
Martin Blaser says the overuse of antibiotics threatens to deplete our bodies of "good" microbes, leaving us vulnerable to an unstoppable plague--an "antibiotic winter"
April 22, 2014 -- Updated 1737 GMT (0137 HKT)
John Sutter asks: Is it possible to eat meat in modern-day America and consider yourself an environmentalist without being a hypocrite?
April 22, 2014 -- Updated 1538 GMT (2338 HKT)
Sally Kohn notes that Meb Keflezighi rightly was called an American after he won the Boston Marathon, but his status in the U.S. once was questioned
April 22, 2014 -- Updated 1256 GMT (2056 HKT)
Denis Hayes and Scott Denman say on this Earth Day, the dawn of the Solar Age is already upon us and the Atomic Age of nuclear power is in decline
April 21, 2014 -- Updated 2036 GMT (0436 HKT)
Retired Coast Guard officer James Loy says a ship captain bears huge responsibility.
April 21, 2014 -- Updated 1708 GMT (0108 HKT)
Peter Bergen says the latest strikes are part of an aggressive U.S. effort to target militants, including a bomb maker
April 21, 2014 -- Updated 1345 GMT (2145 HKT)
Cynthia Lummis and Peter Welch say 16 agencies carry out national intelligence, and their budgets are top secret. We need to know how they are spending our money.
April 21, 2014 -- Updated 1235 GMT (2035 HKT)
Julian Zelizer says President Obama knows more than anyone that he has much at stake in the midterm elections.
April 22, 2014 -- Updated 1255 GMT (2055 HKT)
Eric Sanderson says if you really want to strike a blow for the environment--and your health--this Earth Day, work to get cars out of cities and create transportation alternatives
April 21, 2014 -- Updated 1408 GMT (2208 HKT)
Bruce Barcott looks at the dramatic differences in marijuana laws in Colorado and Louisiana
April 18, 2014 -- Updated 2047 GMT (0447 HKT)
Jim Bell says NASA's latest discovery supports the notion that habitable worlds are probably common in the galaxy.
April 18, 2014 -- Updated 1817 GMT (0217 HKT)
Jay Parini says even the Gospels skip the actual Resurrection and are sketchy on the appearances that followed.
April 18, 2014 -- Updated 1752 GMT (0152 HKT)
Graham Allison says if an unchecked and emboldened Russia foments conflict in a nation like Latvia, a NATO member, the West would have to defend it.
April 18, 2014 -- Updated 1311 GMT (2111 HKT)
John Sutter: Bad news, guys -- the pangolin we adopted is missing.
April 21, 2014 -- Updated 1825 GMT (0225 HKT)
Ben Wildavsky says we need a better way to determine whether colleges are turning out graduates with superior education and abilities.
April 18, 2014 -- Updated 1026 GMT (1826 HKT)
Charles Maclin, program manager working on the search and recovery of Malaysia Flight 370, explains how it works.
April 18, 2014 -- Updated 1250 GMT (2050 HKT)
Jill Koyama says Michael Bloomberg is right to tackle gun violence, but we need to go beyond piecemeal state legislation.
April 17, 2014 -- Updated 1845 GMT (0245 HKT)
Michael Bloomberg and Shannon Watts say Americans are ready for sensible gun laws, but politicians are cowed by the NRA. Everytown for Gun Safety will prove the NRA is not that powerful.
ADVERTISEMENT